Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Edwards Lifesciences
(NY:
EW
)
89.14
-0.97 (-1.08%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Edwards Lifesciences
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Here's How Much $1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today
May 15, 2024
Via
Benzinga
Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint
May 14, 2024
Edwards Lifesciences faces EU antitrust complaint from Meril over patent disputes, intensifying regulatory scrutiny. Recent actions aim to ensure fair competition, affordability, as Meril alleges...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Is It Time To Get Defensive With Healthcare Stocks?
May 13, 2024
Based in Irvine, California, Edwards Lifesciences is a prominent American medical technology firm.
Via
Talk Markets
Assessing Edwards Lifesciences: Insights From 11 Financial Analysts
May 07, 2024
Via
Benzinga
Jim Cramer: These Airline Stocks 'Trade Wildly,' Edwards Lifesciences 'At The Right Level To Buy'
May 01, 2024
Cramer likes Delta Air Lines, United Airlines Holdings. "Now, remember, they're very inexpensive stocks, but they trade wildly. But I do like Delta," he added.
Via
Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $16,000 Today
April 26, 2024
Via
Benzinga
Decoding Edwards Lifesciences's Options Activity: What's the Big Picture?
April 25, 2024
Via
Benzinga
Behind the Scenes of Edwards Lifesciences's Latest Options Trends
April 18, 2024
Via
Benzinga
$1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today
April 12, 2024
Via
Benzinga
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
April 26, 2024
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.
Via
Investor's Business Daily
EW Stock Earnings: Edwards Lifesciences Beats EPS, Beats Revenue for Q1 2024
April 25, 2024
EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff
April 25, 2024
The company also raised its outlook for the year and now expects 8% to 10% sales growth.
Via
Investor's Business Daily
How Is The Market Feeling About Edwards Lifesciences?
April 12, 2024
Via
Benzinga
What Analysts Are Saying About Edwards Lifesciences Stock
April 11, 2024
Via
Benzinga
$100 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth This Much Today
April 02, 2024
Via
Benzinga
The Latest Analyst Ratings For Edwards Lifesciences
March 26, 2024
Via
Benzinga
Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
March 19, 2024
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
March 14, 2024
Via
Benzinga
What 9 Analyst Ratings Have To Say About Edwards Lifesciences
March 07, 2024
Via
Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
February 27, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
February 22, 2024
Via
Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $3,200 Today
February 12, 2024
Via
Benzinga
Earnings Scheduled For February 6, 2024
February 06, 2024
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.
Via
Benzinga
Edwards Lifesciences Earnings Preview
February 05, 2024
Via
Benzinga
Expert Ratings For Edwards Lifesciences
February 02, 2024
Via
Benzinga
FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom
February 12, 2024
FDA to review Abbott's TriClip G4 System for severe tricuspid regurgitation. Circulatory System Devices Panel meeting and insights from the briefing document.
Via
Benzinga
Exposures
Product Safety
These Analysts Boost Their Forecasts On Edwards Lifesciences Following Q4 Results
February 07, 2024
Edwards Lifesciences Corporation (NYSE: EW) reported in-line earnings for its fourth quarter on Tuesday.
Via
Benzinga
Edwards Lifesciences Dips On In-Line Profit, Narrow Sales Beat
February 06, 2024
The company narrowly topped sales expectations and adjusted profit came in line.
Via
Investor's Business Daily
Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday?
February 06, 2024
At noon trading in New York, major equity indices on Wall Street remain directionless as traders evaluate the future course of monetary policy ahead of several speeches by Federal Reserve officials in...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
US Stocks Brace For Another Day In The Red As Rally Loses Steam: Analyst Sees Market Pullback On This Indicator
February 06, 2024
The stock rally that propelled the S&P 500 and the Dow to record highs last week seems to have stalled, with Fed officials remaining non-committal about rate-cut plans.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.